Citadel Advisors’s Ultralife ULBI Stock Holding History
Bought
Maintained
Sold
Other funds holding ULBI
Citadel Advisors's ULBI Position: Q3 2026 in Review
Citadel Advisors increased its Ultralife (ULBI) stake by 13% in Q3 2026, buying an estimated $20.4K and bringing the position to 28,671 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #12387.
Citadel Advisors first reported a position in ULBI in Q1 2014 and has held it in 17 quarters since. The position peaked at $829K in Q3 2024. 56 funds tracked by Wall St. Rank hold ULBI as of Q3 2026.
- Citadel Advisors held 28,671 shares of Ultralife worth $185K as of Q3 2026.
- Citadel Advisors bought 3,388 Ultralife shares in Q3 2026, an estimated $20.4K.
- Ultralife made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #12387 holding.
- Citadel Advisors first reported a position in Ultralife in Q1 2014 and has held it in 17 quarters since.
- Citadel Advisors's Ultralife position peaked at $829K in Q3 2024.
- 56 funds tracked by Wall St. Rank held Ultralife as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.